Pulse Biosciences (PLSE) Change in Receivables (2021 - 2025)

Pulse Biosciences (PLSE) posted Change in Receivables of $259000.0 for Q4 2025, up 1626.67% on a QoQ basis from $15000.0 in Q3 2025.

Analysis

Pulse Biosciences (PLSE) Change in Receivables (2021 - 2025) Analysis & Trends

Pulse Biosciences has reported Change in Receivables for 3 years, with the latest figure at $259000.0 in Q4 2025.

On a quarterly basis, Change in Receivables changed N/A year-over-year to $259000.0 in Q4 2025; TTM through Dec 2025 was $274000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $274000.0, changed N/A from the prior year.
Change in Receivables was $259000.0 for Q4 2025 at Pulse Biosciences, up from $15000.0 in the prior quarter.
The five-year high for Change in Receivables was $259000.0 in Q4 2025, with the low at -$40000.0 in Q1 2022.
Average Change in Receivables over 3 years is $28857.1, with a median of -$5000.0 recorded in 2022.
The largest YoY upside for Change in Receivables was 54.55% in 2022 against a maximum downside of 54.55% in 2022.
Over 3 years, Change in Receivables stood at -$11000.0 in 2021, then jumped by 54.55% to -$5000.0 in 2022, then jumped by 5280.0% to $259000.0 in 2025.
The last three Change in Receivables figures came in at $259000.0 (Q4 2025), $15000.0 (Q3 2025), and -$5000.0 (Q4 2022), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Abbott Laboratories	179.79 Bn	174.18 Bn	7.27 Bn	386.00 Mn
2	Intuitive Surgical	127.69 Bn	122.47 Bn	1.96 Bn	74.90 Mn
3	Medtronic	117.23 Bn	108.41 Bn	6.34 Bn	-224.00 Mn
4	Stryker	103.55 Bn	100.07 Bn	4.50 Bn	177.00 Mn
5	Boston Scientific	63.24 Bn	62.70 Bn	3.85 Bn	46.00 Mn
6	Edwards Lifesciences	49.97 Bn	45.72 Bn	1.35 Bn	10.20 Mn
7	Alcon	32.83 Bn	31.37 Bn	1.68 Bn	-
8	Dexcom	32.30 Bn	30.35 Bn	830.00 Mn	172.10 Mn
9	Steris	20.73 Bn	20.25 Bn	684.20 Mn	-90.00 Mn
10	Pulse Biosciences	3.76 Bn	3.76 Bn	161,000.00	-

Historic Data

Download Data